Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Hemostatic Disorders
>>
Novo Nordisk
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
NovoThirteen
(catridecacog) / Novo Nordisk
NovoEight
(turoctocog alfa) / Novo Nordisk
Rebinyn
(nonacog beta pegol) / Novo Nordisk
vatreptacog alfa
(NN 1731) / Novo Nordisk
Esperoct
(turoctocog alfa pegol) / Novo Nordisk
